Biomarkers in Parkinson's disease: Advances and strategies. - Wikidata - wikimedia - TriplyDB

Biomarkers in Parkinson's disease: Advances and strategies.

Biomarkers in Parkinson's disease: Advances and strategies.

http://www.wikidata.org/entity/Q37431507

about

Recent Advances in the Study of Bipolar/Rod-Shaped Microglia and their Roles in Neurodegeneration.Elevated Hapln2 Expression Contributes to Protein Aggregation and Neurodegeneration in an Animal Model of Parkinson's Disease Proteomic studies associated with Parkinson's disease.Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.Multiple system atrophy: pathogenic mechanisms and biomarkers.Treatments and compositions targeting α-synuclein: a patent review (2010-2016).AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson's disease diagnosis.Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.Potential clinical utility of multiple system atrophy biomarkers.Biomarkers for Parkinson's Disease: Recent Advancement.Recent Advances in Biomarkers for Parkinson's Disease

P2860

Q36376140-1142EE9C-0FDE-47B7-A41C-DE470CCC6D71 Q37194907-32B31D66-5B31-405F-A640-46AB288A98F2 Q38761409-802FE1CD-296F-4040-92D6-B88230236713 Q38765914-55342AF2-6EAE-4F04-BA51-3F8D3DF0F8CB Q38813304-7F187062-4623-49B5-8C7F-43B7A819DA4B Q39007523-903CABE8-99CB-4076-8CA1-79554D298735 Q42347600-23769866-9BA2-41D2-9C38-F3B5A636A270 Q47657093-506BC61F-D21C-4B24-B5C8-53D404CF64A2 Q47663712-EBFAE360-9F91-4658-BB4D-9B7BFD9B49E6 Q49942492-FA81B611-CE54-45CA-AC4A-CBC79E8F0033 Q58572579-996489B1-851B-4EBE-8167-F32F67F11F6F

P2860

Biomarkers in Parkinson's disease: Advances and strategies.

http://www.wikidata.org/entity/Q37431507

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Biomarkers in Parkinson's disease: Advances and strategies.

@en

Biomarkers in Parkinson's disease: Advances and strategies.

@nl

type

label

Biomarkers in Parkinson's disease: Advances and strategies.

@en

Biomarkers in Parkinson's disease: Advances and strategies.

@nl

prefLabel

Biomarkers in Parkinson's disease: Advances and strategies.

@en

Biomarkers in Parkinson's disease: Advances and strategies.

@nl

P1433

Q37431507-1132984C-0CF5-41B7-B253-F2DF6B432056

P1476

Q37431507-73474638-3058-43DF-90CB-6C1FF5B259A7

P2093

Q37431507-13F1A3B8-3BD1-4BD3-A04C-060F3E92B1C6

Q37431507-3AC0337D-839D-4768-BFD7-AB390768F6CB

Q37431507-CB875FF4-5A4F-425B-9C9D-9CD1EA9E1236

P2860

Q37431507-0090FCF9-DCD8-4B8D-86E0-DAFF88D66A39

Q37431507-04589305-DF13-4EF2-B0FB-1B855730D6DA

Q37431507-07AEE6CA-17C5-447B-A5AB-A039D3D68C9F

Q37431507-0942D564-88B8-4493-BBF2-B18B61FC1D52

Q37431507-122157E2-6497-4008-8EB4-47D9E1760AF7

Q37431507-157BC52A-42DF-412C-84BA-A2DD5BFBE7CD

Q37431507-20EBD9C5-0114-4BA8-AB9F-A3643D92DCD2

Q37431507-21050150-E96E-4BB0-888B-A616E7E10F55

Q37431507-30E99950-B18A-45BE-B637-2A0234A079A4

Q37431507-352F4C48-7DAE-4424-BB52-02855AC1D724

P304

Q37431507-FFFFDBC6-E82D-4302-AF8A-9480FB0DB2F5

P31

Q37431507-433A8EF2-5DFB-4A25-B51B-C5DF70B9D4C4

P356

Q37431507-FFA97EAC-4151-461A-B8CA-3C715A53E106

P478

Q37431507-14FC0AD5-F07A-4AEB-8829-E6C0A8E7C56A

P50

Q37431507-F125F630-2CCD-4888-B602-B0E737052573

P577

Q37431507-AD83D2FE-ADD7-4178-917F-4DF334CA542E

P5875

Q37431507-405EC95D-9EB2-4042-BACF-43CA7A8348C7

P698

Q37431507-16036AE7-BE6E-4D02-BA29-108A2AC97804

P921

Q37431507-5E9EBB9C-326B-47B3-B01B-C2AF7390EF87

Q37431507-6DDE64F7-4A93-4E68-BFAD-A0782291BF1C

P932

Q37431507-922465DA-BE80-4BEF-8AE1-C06C6E33B5F2

P356

J.PARKRELDIS.2015.09.048

P1433

Parkinsonism and Related Disorders

P1476

Biomarkers in Parkinson's disease: Advances and strategies.

@en

P2093

Daryl R Jones

http://www.w3.org/2001/XMLSchema#string

Marion Delenclos

http://www.w3.org/2001/XMLSchema#string

Pamela J McLean

http://www.w3.org/2001/XMLSchema#string

P2860

The genetics and neuropathology of Parkinson's disease

Ageing and Parkinson's disease: substantia nigra regional selectivity

Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder.

Imaging neurodegeneration in Parkinson's disease.

Metabolomic profiling in LRRK2-related Parkinson's disease

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.

Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.

P304

S106-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PARKRELDIS.2015.09.048

http://www.w3.org/2001/XMLSchema#string

P478

22 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282518794

http://www.w3.org/2001/XMLSchema#string

P698

26439946

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5120398

http://www.w3.org/2001/XMLSchema#string